JP Stock MarketDetailed Quotes

Rohto Pharmaceutical (4527)

Watchlist
  • 2387.0
  • +29.5+1.25%
20min DelayMarket Closed May 7 15:30 JST
563.76BMarket Cap17.62P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rohto Pharmaceutical (4527) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
Total revenue
88.81B
19.91%81.96B
13.95%308.63B
11.75%68.36B
13.48%270.84B
69.68B
11.14%73.29B
14.88%66.7B
17.06%61.17B
19.54%238.66B
Cost of revenue
37.68B
23.33%36.11B
17.73%133.69B
15.28%29.28B
12.16%113.55B
29.81B
10.52%29.83B
13.25%28.51B
12.09%25.4B
21.28%101.24B
Gross profit
51.13B
17.34%45.85B
11.22%174.94B
9.24%39.08B
14.45%157.29B
39.87B
11.56%43.46B
16.13%38.19B
20.87%35.77B
18.29%137.42B
Operating expense
36.88B
25.17%34.15B
16.00%136B
11.46%27.29B
13.32%117.23B
35.08B
9.53%29.16B
14.46%28.51B
14.93%24.48B
18.71%103.46B
Staff costs
----
----
22.56%26.98B
----
7.52%22.01B
----
----
----
----
11.37%20.47B
Selling and administrative expenses
----
----
6.06%57.51B
----
16.68%54.22B
----
----
----
----
21.92%46.47B
-Selling and marketing expense
----
----
6.06%57.51B
----
16.68%54.22B
----
----
----
----
21.92%46.47B
Research and development costs
----
----
11.37%14.91B
----
21.01%13.39B
----
----
----
----
26.60%11.07B
Depreciation and amortization
----
----
129.39%5.56B
----
3.59%2.42B
----
----
----
----
10.70%2.34B
-Depreciation
----
----
103.07%4.04B
----
1.58%1.99B
----
----
----
----
18.12%1.96B
-Amortization
----
----
249.31%1.52B
----
13.84%436M
----
----
----
----
-16.19%383M
Other operating expenses
----
----
23.23%31.05B
----
8.98%25.19B
----
----
----
----
16.73%23.12B
Operating profit
14.26B
-0.78%11.7B
-2.77%38.94B
4.41%11.79B
17.92%40.05B
4.79B
15.95%14.3B
21.33%9.67B
36.13%11.29B
17.04%33.96B
Net non-operating interest income (expenses)
-15M
-121.12%-79M
-79.35%274M
38.52%374M
85.59%1.33B
412M
150.35%353M
160.71%292M
37.76%270M
495.83%715M
Non-operating interest income
--296M
-46.01%237M
-19.70%1.22B
38.92%439M
58.32%1.52B
--428M
100.00%424M
99.44%355M
24.90%316M
161.41%962M
Non-operating interest expense
--311M
386.15%316M
384.18%949M
41.30%65M
-20.65%196M
--16M
0.00%71M
-4.55%63M
-19.30%46M
-0.40%247M
Net investment income
1.03B
1,451.56%4.48B
14.90%1.07B
12.45%289M
15.19%933M
463M
3.99%-265M
1.27%478M
0.78%257M
111.49%810M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
-24M
-440.72%-1.2B
299.00%2B
-187.01%-221M
-274.18%-1.01B
-164M
-4,120.00%-603M
53.33%-161M
-122.32%-77M
172.31%577M
Income from associates and other participating interests
4M
6,300.00%64M
157.44%166M
-98.65%1M
-259.67%-289M
-358M
-121.25%-17M
-14.29%12M
48.00%74M
26.57%181M
Special income (charges)
-153M
48.59%-73M
-430M
-157.72%-142M
0
0
0
29.91%-246M
2,833.33%246M
-24.49%-1.54B
Less:Other special charges
----
----
---96M
---23M
----
----
----
----
----
219.53%153M
Less:Write off
--153M
-55.76%73M
--526M
167.07%165M
--0
----
----
24.24%246M
-2,833.33%-246M
-32.34%1.39B
Other non-operating income (expenses)
117M
8,550.00%173M
-38.61%310M
-98.89%2M
222.28%505M
-190M
133.67%263M
-12.50%252M
-64.98%180M
-267.89%-413M
Income before tax
15.22B
24.64%15.07B
1.96%42.33B
-1.21%12.09B
21.08%41.52B
4.95B
19.71%14.03B
26.23%10.3B
26.87%12.24B
23.02%34.29B
Income tax
4.65B
-16.29%3.02B
12.41%11.38B
20.70%3.61B
28.79%10.12B
84M
36.45%4.32B
40.74%2.73B
15.58%2.99B
17.56%7.86B
Net income
10.57B
42.06%12.05B
-1.41%30.95B
-8.30%8.48B
18.79%31.39B
4.86B
13.49%9.71B
21.70%7.57B
31.03%9.25B
24.74%26.43B
Net income continuous operations
--10.57B
42.05%12.05B
-1.41%30.95B
-8.29%8.49B
18.79%31.4B
--4.86B
13.51%9.71B
21.71%7.57B
31.01%9.25B
24.74%26.43B
Noncontrolling interests
-57M
28,200.00%283M
-111.82%-54M
-99.38%1M
778.85%457M
85M
34.91%143M
209.09%68M
133.33%161M
-13.33%52M
Net income attributable to the company
10.63B
38.75%11.77B
0.23%31.01B
-6.69%8.48B
17.28%30.94B
4.78B
13.24%9.56B
21.01%7.5B
30.02%9.09B
24.85%26.38B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
10.63B
38.75%11.77B
0.23%31.01B
-6.69%8.48B
17.28%30.94B
4.78B
13.24%9.56B
21.01%7.5B
30.02%9.09B
24.85%26.38B
Gross dividend payment
Basic earnings per share
47.03
40.08%52.0834
0.37%136.11
-6.70%37.18
17.29%135.61
20.95
13.27%41.92
21.01%32.89
30.02%39.85
24.85%115.62
Diluted earnings per share
44.8
40.46%52.0834
0.17%135.44
-6.67%37.08
17.28%135.21
20.88
13.25%41.8
21.03%32.8
30.01%39.73
24.85%115.29
Dividend per share
0
0
33.33%36
0
22.73%27
15
0
20.00%12
0
22.22%22
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Dec 31, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023
Total revenue 88.81B19.91%81.96B13.95%308.63B11.75%68.36B13.48%270.84B69.68B11.14%73.29B14.88%66.7B17.06%61.17B19.54%238.66B
Cost of revenue 37.68B23.33%36.11B17.73%133.69B15.28%29.28B12.16%113.55B29.81B10.52%29.83B13.25%28.51B12.09%25.4B21.28%101.24B
Gross profit 51.13B17.34%45.85B11.22%174.94B9.24%39.08B14.45%157.29B39.87B11.56%43.46B16.13%38.19B20.87%35.77B18.29%137.42B
Operating expense 36.88B25.17%34.15B16.00%136B11.46%27.29B13.32%117.23B35.08B9.53%29.16B14.46%28.51B14.93%24.48B18.71%103.46B
Staff costs --------22.56%26.98B----7.52%22.01B----------------11.37%20.47B
Selling and administrative expenses --------6.06%57.51B----16.68%54.22B----------------21.92%46.47B
-Selling and marketing expense --------6.06%57.51B----16.68%54.22B----------------21.92%46.47B
Research and development costs --------11.37%14.91B----21.01%13.39B----------------26.60%11.07B
Depreciation and amortization --------129.39%5.56B----3.59%2.42B----------------10.70%2.34B
-Depreciation --------103.07%4.04B----1.58%1.99B----------------18.12%1.96B
-Amortization --------249.31%1.52B----13.84%436M-----------------16.19%383M
Other operating expenses --------23.23%31.05B----8.98%25.19B----------------16.73%23.12B
Operating profit 14.26B-0.78%11.7B-2.77%38.94B4.41%11.79B17.92%40.05B4.79B15.95%14.3B21.33%9.67B36.13%11.29B17.04%33.96B
Net non-operating interest income (expenses) -15M-121.12%-79M-79.35%274M38.52%374M85.59%1.33B412M150.35%353M160.71%292M37.76%270M495.83%715M
Non-operating interest income --296M-46.01%237M-19.70%1.22B38.92%439M58.32%1.52B--428M100.00%424M99.44%355M24.90%316M161.41%962M
Non-operating interest expense --311M386.15%316M384.18%949M41.30%65M-20.65%196M--16M0.00%71M-4.55%63M-19.30%46M-0.40%247M
Net investment income 1.03B1,451.56%4.48B14.90%1.07B12.45%289M15.19%933M463M3.99%-265M1.27%478M0.78%257M111.49%810M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets -24M-440.72%-1.2B299.00%2B-187.01%-221M-274.18%-1.01B-164M-4,120.00%-603M53.33%-161M-122.32%-77M172.31%577M
Income from associates and other participating interests 4M6,300.00%64M157.44%166M-98.65%1M-259.67%-289M-358M-121.25%-17M-14.29%12M48.00%74M26.57%181M
Special income (charges) -153M48.59%-73M-430M-157.72%-142M00029.91%-246M2,833.33%246M-24.49%-1.54B
Less:Other special charges -----------96M---23M--------------------219.53%153M
Less:Write off --153M-55.76%73M--526M167.07%165M--0--------24.24%246M-2,833.33%-246M-32.34%1.39B
Other non-operating income (expenses) 117M8,550.00%173M-38.61%310M-98.89%2M222.28%505M-190M133.67%263M-12.50%252M-64.98%180M-267.89%-413M
Income before tax 15.22B24.64%15.07B1.96%42.33B-1.21%12.09B21.08%41.52B4.95B19.71%14.03B26.23%10.3B26.87%12.24B23.02%34.29B
Income tax 4.65B-16.29%3.02B12.41%11.38B20.70%3.61B28.79%10.12B84M36.45%4.32B40.74%2.73B15.58%2.99B17.56%7.86B
Net income 10.57B42.06%12.05B-1.41%30.95B-8.30%8.48B18.79%31.39B4.86B13.49%9.71B21.70%7.57B31.03%9.25B24.74%26.43B
Net income continuous operations --10.57B42.05%12.05B-1.41%30.95B-8.29%8.49B18.79%31.4B--4.86B13.51%9.71B21.71%7.57B31.01%9.25B24.74%26.43B
Noncontrolling interests -57M28,200.00%283M-111.82%-54M-99.38%1M778.85%457M85M34.91%143M209.09%68M133.33%161M-13.33%52M
Net income attributable to the company 10.63B38.75%11.77B0.23%31.01B-6.69%8.48B17.28%30.94B4.78B13.24%9.56B21.01%7.5B30.02%9.09B24.85%26.38B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 10.63B38.75%11.77B0.23%31.01B-6.69%8.48B17.28%30.94B4.78B13.24%9.56B21.01%7.5B30.02%9.09B24.85%26.38B
Gross dividend payment
Basic earnings per share 47.0340.08%52.08340.37%136.11-6.70%37.1817.29%135.6120.9513.27%41.9221.01%32.8930.02%39.8524.85%115.62
Diluted earnings per share 44.840.46%52.08340.17%135.44-6.67%37.0817.28%135.2120.8813.25%41.821.03%32.830.01%39.7324.85%115.29
Dividend per share 0033.33%36022.73%2715020.00%12022.22%22
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.10%
Sample Name
Sample Code
 +2.18%
Sample Name
Sample Code
 +1.23%
4
CNOOC
00883
+1.15%
5
SINOPEC CORP
00386
-1.48%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +68.99%
Sample Name
Sample Code
 +59.23%
Sample Name
Sample Code
 +44.37%
4
Emdoor Information
001314
+43.99%
5
Digital China Group
000034
+29.13%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -